Allurion
OTC: ALURDNatick, US · Founded 2023 · Delaware corporation · 118 employees on LinkedIn · 6 known investors
Find your way into Allurion
1,921 people in our graph share verified history with the Allurion team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Samuel Levy · together at McKinsey & Company (overlapped)
×3knows the team · via Harvard Medical School
×2knows the team · via Harvard University
knows the team · via Harvard Business School
knows the team · via University of Pennsylvania
knows the team · via Yale University
Allurion offers a weight-loss program built around a swallowable, procedureless gastric balloon combined with nutrition coaching, connected digital tools, and AI-driven clinician support. It serves patients seeking non-surgical obesity treatment and works through a network of accredited clinics.
Founders & leadership
Allurion was founded in 2023 by Shantanu Gaur and Samuel Levy.
SG
Shantanu GaurinCo-founderCo-founder of Allurion, which develops a weight-loss platform built around a swallowable gastric balloon along with a virtual care suite, a behavior-change program, and an AI platform for people who are overweight or living with obesity.
SL
Samuel LevyinCo-founderSamuel Levy co-founded Allurion Technologies during medical school and built it into a globally commercialized medical device company operating in over 30 countries; he later founded Lauxera Capital Partners in 2020 to invest in commercial-stage health technology businesses and began his career as a consultant at McKinsey & Company.
BG
Brendan GibbonsinExecutiveBrendan Gibbons is an executive officer at Allurion with 25 years of experience in legal and compliance leadership across four public companies, including recent work on FDA regulatory strategy, EU medical device compliance, and global commercialization in medical technology.
OB
Ojas BuchinChief Operating OfficerOjas Buch is an executive officer at Allurion, a weight-loss platform that combines a swallowable gastric balloon with digital coaching and clinician support. With over 25 years of experience, he has held leadership roles in general management, operations, supply chain, quality and regulatory affairs across multiple continents.
RC
Ram ChuttaniExecutive
JD
Jonathan D WeckerinChief Executive Officer2010–2018Jonathan D Wecker is Executive Officer and Director at Allurion, a weight-loss company offering a swallowable gastric balloon with digital coaching and clinician support. He has held finance, operations, and strategy roles including CFO and CEO, previously scaling a medical device startup to 65 employees and $10M in revenue, and improving EBITDA at a $60M surgery center chain.
BJ
Benoit Jacques Claude ChardonExecutive
CG
Chris GeberthinChief Financial Officer2020–2024Chris Geberth is an executive officer at Allurion with over 30 years of experience in financial operations and executive management across medical device, consumer products, technology, and public accounting firms. He has led fundraising, M&A integration, and financial restructuring efforts and brings expertise in public company reporting, financial planning, and team leadership.
DH
Douglas Hudson LarsonNamed on SEC filing
Board
NL
KG
NC
Investors · 6
Funding
SEC filings, press & company announcements$36.2M disclosed across 6 rounds · 2014–2026
- $3MraisedFeb 2026Source ↗
▶$5MraisedNov 2025 · 16 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2025 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ram ChuttaniExecutive Officer
- Keith JohnsDirector
- Omar IshrakDirector
- Brendan GibbonsExecutive Officer
- Michael DavinDirector
- R. Jason RicheyDirector
- Shantanu GaurExecutive Officer, Director
- Nicholas LewinDirector
- Larson Douglas HudsonDirector
- Ojas BuchExecutive Officer
- Krishna GuptaDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $350K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$7.4MraisedFeb 2025 · 14 investors · Other Health CareRule 506(b)
▶$7.4MraisedFeb 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Milena Alberti-PerezDirector
- Brendan GibbonsExecutive Officer
- Ojas BuchExecutive Officer
- Ram ChuttaniExecutive Officer
- Nicholas LewinDirector
- Keith JohnsDirector
- Michael DavinDirector
- Omar IshrakDirector
- Larson Douglas HudsonDirector
- Krishna GuptaDirector
- Shantanu GaurExecutive Officer, Director
- R. Jason RicheyDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- Sales commissions
- $520.8K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$122.5KraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$122.5KraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Benoit Jacques Claude ChardonExecutive Officer
- Shantanu GaurExecutive Officer, Director
- Nicholas LewinDirector
- Douglas Hudson LarsonDirector
- Omar IshrakDirector
- Ram ChuttaniExecutive Officer
- Chris GeberthExecutive Officer
- Krishna GuptaDirector
- Michael DavinDirector
- Offering amount
- $100.1M
- Amount sold
- $122.5K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$19MraisedFeb 2017 · 45 investors · Other Health CareRule 506(b)
▶$19MraisedFeb 2017 · 45 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Krishna GuptaDirector
- Jonathan D WeckerExecutive Officer, Director
- Shantanu K GaurExecutive Officer, Director
- Samuel G LevyExecutive Officer, Director
- Neil ChhedaDirector
- Offering amount
- $27.3M
- Amount sold
- $19M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJul 2014 · 21 investors · Other Health CareRule 506(b)
▶$1.6MraisedJul 2014 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Samuel G LevyExecutive Officer, Director
- Shantanu K GaurExecutive Officer, Director
- Jonathan D WeckerExecutive Officer, Director
- Amount sold
- $1.6M
- Proceeds to insiders
- $528K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$57.6Mvaluation at IPOJun 2024 · $1.20/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 1
by search overlap
Companies competing with Allurion for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Allurion do?
- Allurion offers a weight-loss program built around a swallowable, procedureless gastric balloon combined with nutrition coaching, connected digital tools, and AI-driven clinician support. It serves patients seeking non-surgical obesity treatment and works through a network of accredited clinics.
- Who founded Allurion?
- Allurion was founded by Shantanu Gaur, Samuel Levy in 2023.
- Who are Allurion's investors?
- Allurion's investors include Kube VC, REMUS Capital, Runway Growth Capital, Citadel, CPH Capital, Romulus Capital.
- How much funding has Allurion raised?
- Allurion has disclosed $36.2M raised across 6 rounds.
- Where is Allurion headquartered?
- Allurion is headquartered in Natick, US.